Vimta Labs Limited - Breakout Setup, Move is ON...#VIMTALABS trading above Resistance of 952
Next Resistance is at 1214
Support is at 691
Here are previous charts:
Chart is self explanatory. Levels of breakout, possible up-moves (where stock may find resistances) and support (close below which, setup will be invalidated) are clearly defined.
Disclaimer: This is for demonstration and educational purpose only. This is not buying or selling recommendations. I am not SEBI registered. Please consult your financial advisor before taking any trade.
VIMTALABS
Topline Growth + Op Leverage ComboChart is self explanatory.
Vimta Labs is one of the well known food testing companies in India.
As per Management guidance,
1. Company is targeting 500 Cr Revenue for 2026; and
2. Margin Expansion upwards of 30%
At expected Revenue of 500 Cr and EBIT margins of 32% by 2026 - EBIT will be around 160 Cr and Net Profit 80 Cr at current NPM of 15%
This equates to an EPS of 37 approximately.
Now here's the tricky part - Finding a reasonable PE for this company.
Ever since it got listed in 2020 at peak PE of 45, the parameter has been declining steadily and is ranging at 20 plus minus 5 now since mid 2021.
At PE of 20, this would mean share price of 20 x 37 EPS = 740 by 2026 which is 25% CAGR approx.
This is a very rough calculation, and things can go wrong, like they did when the company postponed the revenue target from 2025 to 2026.
The price has formed bearish patterns at resistance levels, and it remains to be seen if it can give a breakout in the upside after a small traceback.
Either way, it makes sense to study the business which has been able to 7x its EPS in 3 years, at 25% ROCE.
Note : This is not an investment advice. This post is meant for educational purpose only. Kindly do your own due diligence before investing
FOCUS VIMTALABVannakam Makkale, found some decent breakout from a consolidation range in VIMTALAB. Focus, as per your risk reward. First target will be around 597. As I always say whatever we do must follow risk reward and money management.
Thank you for following and share it with your friends and family 😊
@trade_withpriceaction ❤
ADSC Mini Swing Call // Monday July 18th 2022 // NSE: VIMTALABSADSC Mini Swing Call // Monday July 18th 2022 // NSE: NSE:VIMTALABS
// This is a swing trade call and not an intra-day trade. Please do not expect the stock to go up on the same day of posting or within a few sessions. Please follow the notes along with the posting before, during and after entering the trade //
CMP / LTP: 398
TARGET: 418+ (15% Around)
STOP LOSS: 388 (10% Max)
Standard Notes:
- Please follow the Stop Loss strictly and preferably on a daily closing basis.
- Duration: 3-5Trading Days is suggested for all the mini swings and is an indicative period.
- If SL / Target are not triggered and you still wish to hold the trade, this can be done as long as SL is followed or trailed.
Disclosure: I may or may not have a position in this trade.
Disclaimer: All the recommendations are subject to market conditions. Please trade at your own risks.
VIMTALABS - Uptrend continue Looking at the today's close and current trend of VIMTALABS
Close crossed Monthly Pivots
Stock is out of Squeeze
Closed Marubozu
Also above 20 - SMA on Daily / Weekly/Monthly time frames
The monthly trend is Positive and the Weekly trend is also Changed to +ve
Close Crossed Weekly-13 Upside.
VIMTALABS - New ATH soon! Key Highlights:
1. Bullish market structure on HTF
2. Broke above the horizontal level
3. Support from 200 MA
4. RSI indicates a possible uptrend
5. Good breakout on the weekly time frame
6. Volume lacking at the moment
Disclaimer: This is NOT investment advice. This chart is meant for learning purposes only. Invest your capital at your own risk.
Rajat Kumar Singh (@johntradingwick)
NSE Certified Technical & Fundamental Analyst
VIMTA Labs LONG after multiyear breakoutVimta Labs is engaged in the business of testing food and drugs. It also does contract research for clinical research and pre-clinical studies.
Company was expected to give good quarter and has delivered.
VIMTA LABS: Q2 CONS NET PROFIT 97M RUPEES VS 75M (YOY); 81M (QOQ) || Q2 REVENUE 754M RUPEES VS 593M (YOY); 613M (QOQ)
DII have bought significantly in the last quarter, Some news is coming up
TARGET : See CHART
#VIMTALABS looks to be eligible counter for breakout above 280#VIMTALABS #VIMTA LABORATORIES looks to be a eligible counter for breakout above 280
The weekly charts are showing higher low formations and the daily charts are showing nice moves
On the daily charts the it has made the attempt twice to cross these levels in the last few months
The volume support has been steady/increasing in the recent past
Note : This article is for education and research purpose only , Please consult your financial advisor before taking any investment decisions